P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,130.00
+25.00 (1.19%)
At close: Mar 6, 2026
-2.52%
Market Cap 59.06B
Revenue (ttm) 22.13B
Net Income (ttm) 6.65B
Shares Out 28.88M
EPS (ttm) 230.14
PE Ratio 8.89
Forward PE n/a
Dividend 40.00 (1.88%)
Ex-Dividend Date Dec 29, 2025
Volume 307,786
Average Volume 111,469
Open 2,105.00
Previous Close 2,105.00
Day's Range 2,055.00 - 2,165.00
52-Week Range 1,974.00 - 3,300.00
Beta 0.71
RSI 25.90
Earnings Date Feb 27, 2026

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 201... [Read more]

Industry Commercial Physical and Biological Research
Founded 2010
Employees 99
Stock Exchange KOSDAQ
Ticker Symbol 347740
Full Company Profile

Financial Performance

In 2024, P&K Skin Research Center's revenue was 17.85 billion, an increase of 20.24% compared to the previous year's 14.84 billion. Earnings were 5.82 billion, an increase of 20.84%.

Financial Statements

News

There is no news available yet.